Latest filing published 13 Jan 2023 for PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.).
No signal scores available.
All filings by Michael Spigarelli on record concern PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). The record holds 2 filings, for trades running from 4 April 2021 to 5 January 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 13 January 2023 came the latest disclosure, a transaction in PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.). Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations